Your browser doesn't support javascript.
loading
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.
Widmark, Anders; Gunnlaugsson, Adalsteinn; Beckman, Lars; Thellenberg-Karlsson, Camilla; Hoyer, Morten; Lagerlund, Magnus; Kindblom, Jon; Ginman, Claes; Johansson, Bengt; Björnlinger, Kirsten; Seke, Mihajl; Agrup, Måns; Fransson, Per; Tavelin, Björn; Norman, David; Zackrisson, Björn; Anderson, Harald; Kjellén, Elisabeth; Franzén, Lars; Nilsson, Per.
Afiliação
  • Widmark A; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden. Electronic address: anders.widmark@onkologi.umu.se.
  • Gunnlaugsson A; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund University, Lund, Sweden.
  • Beckman L; Department of Oncology, Sundsvall Hospital, Sundsvall, Sweden.
  • Thellenberg-Karlsson C; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  • Hoyer M; Department of Oncology and Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
  • Lagerlund M; Department of Oncology, Kalmar Hospital, Kalmar, Sweden.
  • Kindblom J; Department of Oncology, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Ginman C; Department of Oncology, Karlstad Central Hospital, Karlstad, Sweden.
  • Johansson B; Department of Oncology, Örebro University Hospital, Örebro University, Örebro, Sweden.
  • Björnlinger K; Department of Oncology, Ryhov Hospital, Jönköping, Sweden.
  • Seke M; Department of Oncology, Centrallasarettet, Växjö, Sweden.
  • Agrup M; Department of Oncology, Linköping University Hospital, Linköping, Sweden.
  • Fransson P; Department of Nursing, Umeå University, Umeå, Sweden.
  • Tavelin B; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  • Norman D; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  • Zackrisson B; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  • Anderson H; Department of Clinical Sciences Lund, Cancer Epidemiology, Lund University, Lund, Sweden.
  • Kjellén E; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund University, Lund, Sweden.
  • Franzén L; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  • Nilsson P; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund University, Lund, Sweden.
Lancet ; 394(10196): 385-395, 2019 08 03.
Article em En | MEDLINE | ID: mdl-31227373
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Fracionamento da Dose de Radiação Tipo de estudo: Clinical_trials / Guideline Aspecto: Patient_preference Limite: Aged / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Lancet Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Fracionamento da Dose de Radiação Tipo de estudo: Clinical_trials / Guideline Aspecto: Patient_preference Limite: Aged / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Lancet Ano de publicação: 2019 Tipo de documento: Article